List of Tables
Table 1. Global Neoantigen Targeted Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Off-the-shelf Neoantigen
Table 3. Key Players of Personalized Neoantigen
Table 4. Global Neoantigen Targeted Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Neoantigen Targeted Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Neoantigen Targeted Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Neoantigen Targeted Therapy Market Share by Region (2020-2025)
Table 8. Global Neoantigen Targeted Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Neoantigen Targeted Therapy Market Share by Region (2026-2031)
Table 10. Neoantigen Targeted Therapy Market Trends
Table 11. Neoantigen Targeted Therapy Market Drivers
Table 12. Neoantigen Targeted Therapy Market Challenges
Table 13. Neoantigen Targeted Therapy Market Restraints
Table 14. Global Neoantigen Targeted Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Neoantigen Targeted Therapy Market Share by Players (2020-2025)
Table 16. Global Top Neoantigen Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neoantigen Targeted Therapy as of 2024)
Table 17. Ranking of Global Top Neoantigen Targeted Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Neoantigen Targeted Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Neoantigen Targeted Therapy, Headquarters and Area Served
Table 20. Global Key Players of Neoantigen Targeted Therapy, Product and Application
Table 21. Global Key Players of Neoantigen Targeted Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Neoantigen Targeted Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Neoantigen Targeted Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global Neoantigen Targeted Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Neoantigen Targeted Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global Neoantigen Targeted Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Neoantigen Targeted Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global Neoantigen Targeted Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Neoantigen Targeted Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America Neoantigen Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Neoantigen Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Neoantigen Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Neoantigen Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Neoantigen Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Neoantigen Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Neoantigen Targeted Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Neoantigen Targeted Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Neoantigen Targeted Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Neoantigen Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Neoantigen Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Neoantigen Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Neoantigen Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Neoantigen Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Neoantigen Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. BioNTech SE Company Details
Table 47. BioNTech SE Business Overview
Table 48. BioNTech SE Neoantigen Targeted Therapy Product
Table 49. BioNTech SE Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 50. BioNTech SE Recent Development
Table 51. Gritstone Bio Company Details
Table 52. Gritstone Bio Business Overview
Table 53. Gritstone Bio Neoantigen Targeted Therapy Product
Table 54. Gritstone Bio Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 55. Gritstone Bio Recent Development
Table 56. Genocea Biosciences Company Details
Table 57. Genocea Biosciences Business Overview
Table 58. Genocea Biosciences Neoantigen Targeted Therapy Product
Table 59. Genocea Biosciences Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 60. Genocea Biosciences Recent Development
Table 61. Moderna Company Details
Table 62. Moderna Business Overview
Table 63. Moderna Neoantigen Targeted Therapy Product
Table 64. Moderna Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 65. Moderna Recent Development
Table 66. Agenus Company Details
Table 67. Agenus Business Overview
Table 68. Agenus Neoantigen Targeted Therapy Product
Table 69. Agenus Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 70. Agenus Recent Development
Table 71. Immatics Company Details
Table 72. Immatics Business Overview
Table 73. Immatics Neoantigen Targeted Therapy Product
Table 74. Immatics Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 75. Immatics Recent Development
Table 76. Advaxis Company Details
Table 77. Advaxis Business Overview
Table 78. Advaxis Neoantigen Targeted Therapy Product
Table 79. Advaxis Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 80. Advaxis Recent Development
Table 81. Precision Biologics Company Details
Table 82. Precision Biologics Business Overview
Table 83. Precision Biologics Neoantigen Targeted Therapy Product
Table 84. Precision Biologics Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 85. Precision Biologics Recent Development
Table 86. Gilead Sciences Company Details
Table 87. Gilead Sciences Business Overview
Table 88. Gilead Sciences Neoantigen Targeted Therapy Product
Table 89. Gilead Sciences Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 90. Gilead Sciences Recent Development
Table 91. Cellular Biomedicine Group Company Details
Table 92. Cellular Biomedicine Group Business Overview
Table 93. Cellular Biomedicine Group Neoantigen Targeted Therapy Product
Table 94. Cellular Biomedicine Group Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 95. Cellular Biomedicine Group Recent Development
Table 96. Achilles Therapeutics Company Details
Table 97. Achilles Therapeutics Business Overview
Table 98. Achilles Therapeutics Neoantigen Targeted Therapy Product
Table 99. Achilles Therapeutics Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 100. Achilles Therapeutics Recent Development
Table 101. Merck and Co Company Details
Table 102. Merck and Co Business Overview
Table 103. Merck and Co Neoantigen Targeted Therapy Product
Table 104. Merck and Co Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 105. Merck and Co Recent Development
Table 106. Beijing Kati Medical Technology Company Details
Table 107. Beijing Kati Medical Technology Business Overview
Table 108. Beijing Kati Medical Technology Neoantigen Targeted Therapy Product
Table 109. Beijing Kati Medical Technology Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 110. Beijing Kati Medical Technology Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Neoantigen Targeted Therapy Picture
Figure 2. Global Neoantigen Targeted Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Neoantigen Targeted Therapy Market Share by Type: 2024 VS 2031
Figure 4. Off-the-shelf Neoantigen Features
Figure 5. Personalized Neoantigen Features
Figure 6. Global Neoantigen Targeted Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Neoantigen Targeted Therapy Market Share by Application: 2024 VS 2031
Figure 8. Colorectal Cancer Case Studies
Figure 9. Renal Cell Carcinoma Case Studies
Figure 10. Non-Small Cell Lung cancer Case Studies
Figure 11. Bone Cancer Case Studies
Figure 12. Gynecological Cancer Case Studies
Figure 13. Others Case Studies
Figure 14. Neoantigen Targeted Therapy Report Years Considered
Figure 15. Global Neoantigen Targeted Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Neoantigen Targeted Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Neoantigen Targeted Therapy Market Share by Region: 2024 VS 2031
Figure 18. Global Neoantigen Targeted Therapy Market Share by Players in 2024
Figure 19. Global Top Neoantigen Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neoantigen Targeted Therapy as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Neoantigen Targeted Therapy Revenue in 2024
Figure 21. North America Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Neoantigen Targeted Therapy Market Share by Country (2020-2031)
Figure 23. United States Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Neoantigen Targeted Therapy Market Share by Country (2020-2031)
Figure 27. Germany Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Neoantigen Targeted Therapy Market Share by Region (2020-2031)
Figure 35. China Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Neoantigen Targeted Therapy Market Share by Country (2020-2031)
Figure 43. Mexico Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Neoantigen Targeted Therapy Market Share by Country (2020-2031)
Figure 47. Turkey Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. BioNTech SE Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 51. Gritstone Bio Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 52. Genocea Biosciences Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 53. Moderna Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 54. Agenus Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 55. Immatics Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 56. Advaxis Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 57. Precision Biologics Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 58. Gilead Sciences Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 59. Cellular Biomedicine Group Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 60. Achilles Therapeutics Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 61. Merck and Co Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 62. Beijing Kati Medical Technology Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
